Baseline | At End of Study | |||
---|---|---|---|---|
n | % | n | % | |
Charlson Comorbidities | ||||
Myocardial infarction | 27,304 | (6.02) | 53,774 | (11.85) |
Congestive heart failure | 26,041 | (5.74) | 60,426 | (13.32) |
Peripheral vascular disease | 13,399 | (2.95) | 33,863 | (7.46) |
Cerebrovascular disease | 23,881 | (5.26) | 56,297 | (12.41) |
Hemiplegia or paraplegia | 3738 | (0.82) | 8536 | (1.88) |
Dementia | 8890 | (1.96) | 31,659 | (6.98) |
Chronic pulmonary disease | 70,227 | (15.48) | 122,785 | (27.06) |
Rheumatologic disease | 8161 | (1.80) | 18,223 | (4.02) |
Peptic ulcer disease | 11,674 | (2.57) | 27,142 | (5.98) |
Diabetes without chronic complications | 31,098 | (6.85) | 58,389 | (12.87) |
Diabetes with chronic complications | 7503 | (1.65) | 23,390 | (5.16) |
Renal disease | 10,231 | (2.25) | 34,560 | (7.62) |
Any malignancy, including leukemia and lymphoma | 26,853 | (5.92) | 69,637 | (15.35) |
Metastatic solid tumor | 4784 | (1.05) | 18,231 | (4.02) |
Mild liver disease | 6524 | (1.44) | 16,860 | (3.72) |
Moderate or severe liver disease | 968 | (0.21) | 2782 | (0.61) |
AIDS/HIV | 230 | (0.05) | 407 | (0.09) |
Number of Charlson Comorbidities | ||||
0 | 285,417 | (63.2) | 179,802 | (39.6) |
1-2 | 140,101 | (28.1) | 181,353 | (40.0) |
≥3 | 28,216 | (8.7) | 92,579 | (20.4) |